GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose

Clinical trial NCT03943875 · COMPLETED

Trial details

NCT number: NCT03943875
Sponsor: The University of Texas Medical Branch, Galveston
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Immunization Efficacy Human Papilloma Virus

Start date: 2019-06-17
Primary completion: 2025-01-13
Enrollment: 767

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.